DCF — CAYUGA MEDICAL CENTER AT ITHACA
Enterprise Value: $-610.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-610.0M
Enterprise Value
$-190.6M
PV of Cash Flows
$-419.4M
PV of Terminal Value
$-675.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $311.4M | $-39.3M | -13.0% | $-52.5M | $-47.7M |
| Year 2 | $320.8M | $-37.3M | -12.0% | $-50.8M | $-42.0M |
| Year 3 | $330.4M | $-35.1M | -11.0% | $-49.1M | $-36.9M |
| Year 4 | $340.3M | $-34.4M | -10.0% | $-48.8M | $-33.4M |
| Year 5 | $350.5M | $-34.6M | -10.0% | $-49.4M | $-30.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-610.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$302.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13116959162024078
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5